News / All News / Article

Penguin On-Site | Founder and CEO Dr. Zou Xiaoliang Leads Weiming Penguin’s Delegation to the 7th World Health Expo

Article images may contain Chinese text.

Weiming Penguin Presents Its AI Innovations at the 7th World Health Expo: Digital Transformation Empowers a New Future for the Pharmaceutical Eco-

system. Industry leaders including Guo Yanhong, Huang Huabo, and Liu Yonghao discuss new paths for integrating AI into the healthcare industry.




Image


On April 8, 2025, the 7th World Health Expo opened at the Wuhan Optics Valley Science and Technology Center. Under the theme “AI Empowerment, Healthy Living,” this year’s expo attracted nearly 700 exhibitors from 18 countries and regions around the world. As a leading company in the pharmaceutical industry’s digital transformation, Weiming Penguin attended with a delegation led by its founder and CEO, Dr. Zou Xiaoliang, and unveiled several innovations. During the event, prominent guests including Guo Yanhong, director of the Department of Medical Administration at China’s National Health Commission; pharmaceutical policy research expert Huang Huabo; and Liu Yonghao, chairman of New Hope Group, held in-depth discussions on integrating AI into the healthcare industry, offering the industry forward-looking insights.

Image

1. Industry Leaders Discuss New Trends in Digital Transformation
Image

At the “AI + Pharmaceutical Ecosystem” roundtable, guests examined the direction of industry change from policy, technology, and market perspectives.


01
AI Is Reshaping How Healthcare Resources Are Allocated
Image




Guo Yanhong, director of the Department of Medical Administration at China’s National Health Commission, believes that AI is reshaping how healthcare resources are allocated. Through big data analytics, we can precisely identify gaps in regional healthcare resources—for example, by extending the diagnostic and treatment capabilities of Grade III Class A hospitals to primary care settings.

Weiming Penguin’s channel distribution data analytics technology provides crucial support for optimizing pharmaceutical supply chains, playing a particularly important role in achieving a balanced distribution of healthcare resources at the county level.

Image


02
The Pharmaceutical Industry Can Learn from an Integrated “Data + Scenarios + Ecosystem” Model
Image




Drawing on experience in agricultural digitalization, Liu Yonghao, chairman of New Hope Group, suggested that the pharmaceutical industry could learn from an integrated “data + scenarios + ecosystem” model.

For example, using AI traceability technology to safeguard the quality of traditional Chinese medicinal materials is precisely the kind of innovative practice Weiming Penguin is pursuing in traditional Chinese medicine supply chain management. Weiming Penguin will work with agricultural enterprises to explore collaborative innovation between agricultural and livestock supply chains and pharmaceutical supply chains.

Image


03
AI’s Role in Drug Discovery and Development Has Evolved from a Supporting Tool into a Core Engine
Image




Focusing on technological breakthroughs, Wei Shengbin, secretary-general of the China Pharmaceutical Innovation and Research Development Association, emphasized that AI’s role in drug discovery and development has evolved from a supporting tool into a core engine. He also called on the industry to strengthen its AI algorithm patent portfolios to avoid technological homogenization.


Image



04
Digital Penetration in the Primary Care Market Is Key to Future Growth
Image




Based on an analysis of market dynamics, Sun Yang, a pharmaceutical industry analyst at Frost & Sullivan, noted that digital penetration in the primary care market remains below 30%, making it a key area for future growth.

Working with the DingTalk ecosystem to serve leading key manufacturers, Weiming Penguin is focusing on services for major hospitals and partnerships with key DTP pharmacies, while further expanding outlet services and partner selection across retail, county-level, and primary care markets.

05
China’s National Healthcare Security Information Platform Provides a Data Foundation for AI Applications
Image




Discussing policy direction, Huang Huabo, director of the Department of Medical Services Management at China’s National Healthcare Security Administration, emphasized that the national healthcare security information platform provides a data foundation for AI applications. The administration is studying the inclusion of AI assessments of appropriate medication use in pilot DRG/DIP payment reforms.

Image


Image

2. Weiming Penguin: Driving Industry Change with AI Technology
Image

During a booth interview, Weiming Penguin founder and CEO Dr. Zou Xiaoliang gave a systematic presentation of several company achievements from 2024–2025:


01
AI + BI Intelligent Analytics System
Image




By analyzing channel data in real time, the accuracy of outlet coverage rates increased by 40%. A collaboration with an anonymized pharmaceutical holding company was selected as an “Annual Digital Transformation Benchmark.”

02
An End-to-End Closed Data Loop
Image




The Deepseek system covers data from pharmaceutical companies through to outlets, increasing supply chain efficiency by 35% at a TOP10 pharmaceutical company

03
Forecasting, Potential Analysis, and Industry Co-Creation
Image




Recognized as a “Beijing Innovative SME,” the company also jointly published 10 industry white papers, with brand exposure increasing by 150%.


“The experts’ insights align closely with our technical practices,” Zou Xiaoliang said. “For example, to address the need to extend resources to local communities mentioned by Director Guo of the National Health Commission, we are using AI algorithms to optimize county-level pharmaceutical delivery routes. Meanwhile, the healthcare security payment reforms emphasized by Director Huang of the National Healthcare Security Administration are driving us to develop a SaaS product line that improves quality and efficiency.”
Image

3. Partnerships and Outlook: Building a Shared Healthcare Ecosystem
Image

During the expo, Weiming Penguin reached preliminary cooperation agreements with several companies. Looking ahead, the integration of AI and the healthcare industry will create new business sectors on a trillion scale.

Chen Dongsheng, president of the Hubei Chushang Federation, noted that AI is achieving breakthroughs in areas such as new drug discovery and development, gene editing, remote diagnosis and treatment, and surgical robotics, driving a comprehensive upgrade of China’s healthcare industry. He specifically mentioned that the combination of AI and biotechnology will reshape healthcare models—for example, by accelerating drug discovery and optimizing diagnosis and treatment processes through intelligent algorithms, while also driving the transition to smarter medical devices. Weiming Penguin’s technological innovations provide the industry with a complete solution, from improving efficiency to restructuring ecosystems.

Image
The 7th World Health Expo not only showcased breakthroughs in AI technology but also highlighted the determination of companies such as Weiming Penguin to empower the industry through technology. As data becomes a new kind of “medicinal material” and algorithms become new “prescriptions,” we are witnessing a “paradigm revolution” in the healthcare industry.
Image